HeartSciences (HSCSW) Notes Payables (2022 - 2026)

HeartSciences (HSCSW) has reported Notes Payables for 5 consecutive years, with $3.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Notes Payables rose 41.98% year-over-year to $3.6 million; the trailing twelve-month figure through Apr 2026 stood at $3.6 million (up 41.98% YoY), and the FY2026 full-year result was $3.6 million, up 41.98% from the prior year.
• Notes Payables climbed to $3.6 million in Q2 2026 per HSCSW's latest filing, from $2.6 million in the prior quarter.
• Across five years, Notes Payables topped out at $3.6 million in Q2 2026 and bottomed at $130000.0 in Q3 2022.
• Historically, Notes Payables has averaged $1.4 million across 5 years, with a median of $1.3 million in 2022.
• The widest YoY moves for Notes Payables: up 410.23% in 2025, down 78.87% in 2025.
• Over 5 years, Notes Payables stood at $1.1 million in 2022, then gained by 25.41% to $1.4 million in 2023, then jumped by 67.01% to $2.4 million in 2024, then increased by 7.79% to $2.6 million in 2025, then soared by 41.98% to $3.6 million in 2026.
• According to Business Quant data, Notes Payables over the past three periods registered $3.6 million, $2.6 million, and $500000.0 for Q2 2026, Q4 2025, and Q4 2025 respectively.